Erdheim–Chester Disease With Eyelid and Orbital Involvement: A Review of Treatment Modalities at One Institution From 2014 to 2022
Sharma M, Stevens S, Maeng M, Nagornaya N, Bhatia R, Wester S. Erdheim–Chester Disease With Eyelid and Orbital Involvement: A Review of Treatment Modalities at One Institution From 2014 to 2022. Ophthalmic Plastic And Reconstructive Surgery 2024, 40: 497-503. PMID: 38427815, PMCID: PMC11377047, DOI: 10.1097/iop.0000000000002619.Peer-Reviewed Original ResearchErdheim-Chester diseaseBascom Palmer Eye InstituteEye InstituteOrbital involvementTreatment of Erdheim-Chester diseaseErdheim-Chester disease patientsCase of Erdheim-Chester diseaseIntolerable side effectsRetrospective chart reviewFavorable treatment optionRelevant laboratory resultsReview of treatmentOphthalmic examinationDry eyeOphthalmic symptomsReducing proptosisBRAF inhibitorsECD patientsPathology reportsOphthalmic institutionsOrbital diseaseChart reviewTreatment modalitiesErdheim-ChesterPrimary treatment
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply